These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25931806)

  • 1. Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial.
    Simmons PA; Carlisle-Wilcox C; Vehige JG
    Clin Ophthalmol; 2015; 9():657-64. PubMed ID: 25931806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
    Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
    Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial.
    Downie LE; Hom MM; Berdy GJ; El-Harazi S; Verachtert A; Tan J; Liu H; Carlisle-Wilcox C; Simmons P; Vehige J
    Ocul Surf; 2020 Jan; 18(1):148-157. PubMed ID: 31734510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study.
    Aragona P; Benítez-Del-Castillo JM; Coroneo MT; Mukherji S; Tan J; Vandewalle E; Vingrys A; Liu H; Carlisle-Wilcox C; Vehige J; Simmons PA
    Clin Ophthalmol; 2020; 14():2951-2963. PubMed ID: 33061281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
    Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
    Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.
    Wallerstein A; Jackson WB; Chambers J; Moezzi AM; Lin H; Simmons PA
    Clin Ophthalmol; 2018; 12():839-848. PubMed ID: 29765198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
    Essa L; Laughton D; Wolffsohn JS
    Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial.
    Donnenfeld E; Coats J; Barbour K; Ryan R; Joshi NR; Periman LM
    BMC Ophthalmol; 2024 Oct; 24(1):442. PubMed ID: 39379885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
    Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
    BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
    Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
    Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.
    Simmons PA; Liu H; Carlisle-Wilcox C; Vehige JG
    Clin Ophthalmol; 2015; 9():665-75. PubMed ID: 25931807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
    Davitt WF; Bloomenstein M; Christensen M; Martin AE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a formulated eye drop with
    Tan J; Jia T; Liao R; Stapleton F
    Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans.
    Radkar P; Lakshmanan PS; Mary JJ; Chaudhary S; Durairaj SK
    Ophthalmol Ther; 2021 Sep; 10(3):581-599. PubMed ID: 34129210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye.
    Chhadva P; Lee T; Sarantopoulos CD; Hackam AS; McClellan AL; Felix ER; Levitt RC; Galor A
    Ophthalmology; 2015 Aug; 122(8):1675-80. PubMed ID: 25983214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving ocular surface comfort in contact lens wearers.
    Fernández-Jimenez E; Diz-Arias E; Peral A
    Cont Lens Anterior Eye; 2022 Jun; 45(3):101544. PubMed ID: 34840071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.
    Park CH; Lee HK; Kim MK; Kim EC; Kim JY; Kim TI; Kim HK; Song JS; Yoon KC; Lee DH; Chung TY; Choi CY; Kim HS
    BMC Ophthalmol; 2019 Jun; 19(1):131. PubMed ID: 31208393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
    Cömez AT; Tufan HA; Kocabıyık O; Gencer B
    Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.